Despite this, there is currently no convincing data indicating the ability of breast carcinomas to capture radioiodine in vivo in a therapeutic amount, which has prompted researchers to study the role of NIS in tumor biology, the mechanisms of its expression, processing, transport, and glycosylation [15]. The gene discussed is SLC5A5; the disease is breast carcinoma.